Zafgen Company Profile (NASDAQ:ZFGN)

About Zafgen

Zafgen logoZafgen, Inc. is a biopharmaceutical company. The Company is focused on improving the health and well-being of patients affected by obesity and complex metabolic disorders. The Company's lead product candidate, Beloranib, is a twice-weekly subcutaneous injection being developed for the treatment of multiple indications, including severe obesity in rare diseases, such as Prader-Willi syndrome (PWS) and hypothalamic injury-associated obesity (HIAO), including craniopharyngioma-associated obesity. Beloranib is in Phase III stage of development for PWS. It is also developing ZGN-839, a liver-targeted methionine aminopeptidase 2 (MetAP2) inhibitor, for the treatment of nonalcoholic steatohepatitis (NASH) and abdominal obesity, as well as other second-generation MetAP2 inhibitors for the treatment of severe obesity. It is also evaluating additional MetAP2 inhibitors beyond Beloranib as a development candidate for the treatment of severe obesity in the general population.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ZFGN
  • CUSIP:
Key Metrics:
  • Previous Close: $3.20
  • 50 Day Moving Average: $3.15
  • 200 Day Moving Average: $5.36
  • 52-Week Range: $2.90 - $36.49
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.55
  • P/E Growth: 0.00
  • Market Cap: $87.45M
  • Outstanding Shares: 27,329,000
  • Beta: -1.63
Profitability:
  • Return on Equity: -46.27%
  • Return on Assets: -42.04%
Debt:
  • Debt-to-Equity Ratio: 0.01%
  • Current Ratio: 14.43%
  • Quick Ratio: 14.43%
Additional Links:
Companies Related to Zafgen:

Analyst Ratings

Consensus Ratings for Zafgen (NASDAQ:ZFGN) (?)
Ratings Breakdown: 5 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.29)
Consensus Price Target: $16.83 (426.04% upside)
Analysts' Ratings History for Zafgen (NASDAQ:ZFGN)
Show:
DateFirmActionRatingPrice TargetDetails
9/20/2016FBR & CoReiterated RatingHoldView Rating Details
8/25/2016Cowen and CompanyReiterated RatingBuy$60.00View Rating Details
7/21/2016Canaccord GenuitySet Price TargetHold$7.00 -> $4.00View Rating Details
7/20/2016Leerink SwannReiterated RatingMarket Perform$6.00View Rating Details
4/5/2016Royal Bank Of CanadaReiterated RatingOutperform$19.00View Rating Details
2/20/2016SunTrust Banks Inc.Reiterated RatingHold$7.00View Rating Details
10/16/2015JMP SecuritiesDowngradeOutperform -> Market PerformView Rating Details
(Data available from 9/27/2014 forward)

Earnings

Earnings History for Zafgen (NASDAQ:ZFGN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2016        
5/10/2016Q116($0.74)($0.65)ViewListenView Earnings Details
3/9/2016Q415($0.80)($0.85)ViewN/AView Earnings Details
11/10/2015Q3($0.79)($0.73)$80.60 million$78.20 millionViewListenView Earnings Details
8/11/2015Q215($0.71)($0.66)ViewListenView Earnings Details
5/12/2015Q115($0.52)($0.53)ViewListenView Earnings Details
3/19/2015Q414($0.84)($0.48)ViewListenView Earnings Details
11/11/2014Q314($0.87)($0.65)ViewN/AView Earnings Details
8/13/2014Q214($0.28)($2.96)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Zafgen (NASDAQ:ZFGN)
Current Year EPS Consensus Estimate: $-2.57 EPS
Next Year EPS Consensus Estimate: $-2.06 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.75)($0.75)($0.75)
Q2 20162($0.66)($0.62)($0.64)
Q3 20162($0.76)($0.68)($0.72)
Q4 20162($0.89)($0.69)($0.79)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Zafgen (NASDAQ:ZFGN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Zafgen (NASDAQ:ZFGN)
Insider Ownership Percentage: 20.30%
Institutional Ownership Percentage: 62.83%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/29/2016Thomas E HughesInsiderBuy10,000$3.00$30,000.00View SEC Filing  
7/26/2016Patricia L. AllenCFOBuy16,000$3.12$49,920.00View SEC Filing  
7/22/2016Frances K HellerDirectorBuy10,000$2.99$29,900.00View SEC Filing  
7/22/2016Thomas E. HughesInsiderBuy5,000$3.02$15,100.00View SEC Filing  
2/12/2016James E FlynnInsiderBuy64,545$6.25$403,406.25View SEC Filing  
2/11/2016James E FlynnInsiderBuy267,493$6.02$1,610,307.86View SEC Filing  
9/24/2015Kevin P StarrDirectorSell136,579$43.90$5,995,818.10View SEC Filing  
9/18/2015Avi Y GoldbergDirectorSell5,000$45.00$225,000.00View SEC Filing  
9/18/2015Thomas E. HughesCEOSell45,626$42.53$1,940,473.78View SEC Filing  
9/17/2015Dennis D. KiminsiderSell39,407$40.00$1,576,280.00View SEC Filing  
6/10/2015Avi Y GoldbergDirectorSell3,000$35.00$105,000.00View SEC Filing  
6/1/2015Avi Y GoldbergDirectorSell2,000$32.23$64,460.00View SEC Filing  
6/19/2014Alicia SecorInsiderBuy4,000$20.00$80,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Zafgen (NASDAQ:ZFGN)
DateHeadline
News IconPrice Target in the Spotlight: Zafgen, Inc. (NASDAQ:ZFGN) - Theriponadvance.com (NASDAQ:ZFGN)
theriponadvance.com - September 23 at 5:01 AM
News IconInvestor's Alert: Zafgen, Inc. (NASDAQ:ZFGN), Harmonic Inc. (NASDAQ:HLIT) - Newburgh Press (NASDAQ:ZFGN)
newburghpress.com - September 23 at 5:01 AM
News IconZafgen Inc Increases Again; Strong Momentum for Buyers - Post News (NASDAQ:ZFGN)
www.kentuckypostnews.com - September 22 at 5:04 AM
4-traders.com logoZafgen : Initiates Multiple Ascending Dose Cohorts in Phase 1 Clinical Trial of ZGN-1061 (NASDAQ:ZFGN)
www.4-traders.com - September 21 at 7:45 PM
smarteranalyst.com logoStock Update (NASDAQ:ZFGN): Zafgen Inc Initiates Multiple Ascending Dose Cohorts in Phase 1 Clinical Trial of ZGN ... - Smarter Analyst (NASDAQ:ZFGN)
www.smarteranalyst.com - September 21 at 12:03 PM
capitalcube.com logoZafgen, Inc. :ZFGN-US: Earnings Analysis: Q2, 2016 By the Numbers : September 20, 2016 (NASDAQ:ZFGN)
www.capitalcube.com - September 21 at 12:03 PM
streetinsider.com logoZafgen (ZFGN) Commences MAD Cohorts of ZGN-1061 Phase 1 - StreetInsider.com (NASDAQ:ZFGN)
www.streetinsider.com - September 20 at 8:33 AM
publicnow.com logoZafgen Initiates Multiple Ascending Dose Cohorts in Phase 1 Clinical Trial of ZGN-1061 (NASDAQ:ZFGN)
www.publicnow.com - September 20 at 8:33 AM
News IconMarket Review: Watching Session Activity of Zafgen, Inc. (NASDAQ:ZFGN) Shares - Post News (NASDAQ:ZFGN)
www.kentuckypostnews.com - September 9 at 7:50 PM
News IconPlacing Zafgen, Inc. (NASDAQ:ZFGN) Shares Under the Microscope - National Daily Press (NASDAQ:ZFGN)
www.nationaldailypress.com - September 9 at 5:25 AM
News IconStock Tracker: Earnings & Estimates for Zafgen, Inc. (NASDAQ:ZFGN) - Frisco Fastball (NASDAQ:ZFGN)
friscofastball.com - September 8 at 12:10 PM
News IconZafgen Inc(NASDAQ:ZFGN) Upward Trend - Live Trading News (NASDAQ:ZFGN)
www.livetradingnews.com - September 5 at 7:06 PM
News IconInvestors are Sharpening Their Focus on Shares of Zafgen, Inc. (NASDAQ:ZFGN) - Post News (NASDAQ:ZFGN)
www.kentuckypostnews.com - August 31 at 5:28 AM
News IconStocks Trending Alert: Zafgen Inc (NASDAQ:ZFGN), Xtera Communications Inc (NASDAQ:XCOM), Yahoo! Inc ... - NYSE Journal (press release) (NASDAQ:ZFGN)
stockznews.com - August 29 at 8:20 PM
seekingalpha.com logoZafgen: Too Cheap To Ignore - Seeking Alpha (NASDAQ:ZFGN)
seekingalpha.com - August 26 at 11:17 AM
News IconWorth Watching Stocks in the Spotlight: Zafgen Inc (NASDAQ:ZFGN), Pan American Silver Corp. (USA) (NASDAQ:PAAS) - NYSE Journal (press release) (NASDAQ:ZFGN)
stockznews.com - August 23 at 8:32 PM
finance.yahoo.com logoZAFGEN, INC. Financials (NASDAQ:ZFGN)
finance.yahoo.com - August 13 at 7:51 PM
News IconActive Runners: Intermolecular Inc (NASDAQ:IMI), Zafgen Inc ... - NYSE Journal (press release) (NASDAQ:ZFGN)
stockznews.com - August 8 at 8:39 PM
biz.yahoo.com logoZAFGEN, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:ZFGN)
biz.yahoo.com - August 5 at 11:32 AM
twst.com logoZafgen Inc.: Zafgen Reports Second Quarter 2016 Financial Results (NASDAQ:ZFGN)
www.twst.com - August 4 at 8:54 PM
sg.finance.yahoo.com logoZafgen reports 2Q loss (NASDAQ:ZFGN)
sg.finance.yahoo.com - August 4 at 8:54 PM
finance.yahoo.com logoZafgen to Present at Canaccord Genuity’s 36th Annual Growth Conference (NASDAQ:ZFGN)
finance.yahoo.com - August 3 at 8:49 PM
benzinga.com logoZFGN: Insiders vs. Shorts (NASDAQ:ZFGN)
www.benzinga.com - July 30 at 3:16 PM
fortune.com logoAnalysts: Zafgen, Inc. (NASDAQ:ZFGN) stock is worth $4.5 ... - Review Fortune (NASDAQ:ZFGN)
reviewfortune.com - July 29 at 8:43 PM
finance.yahoo.com logoZafgen (ZFGN) Is in Oversold Territory: What's Next? (NASDAQ:ZFGN)
finance.yahoo.com - July 29 at 9:53 AM
News IconHot Biotech Stocks Recap: Zafgen, Inc. (NASDAQ:ZFGN), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - The Voice Registrar (NASDAQ:ZFGN)
voiceregistrar.com - July 28 at 8:56 PM
News IconHC Stocks Overview: Celgene Corporation (NASDAQ:CELG) Zafgen Inc (NASDAQ:ZFGN) - share market updates (press release) (NASDAQ:ZFGN)
sharemarketupdates.com - July 25 at 8:38 PM
fortune.com logoCurrent Zafgen, Inc. (NASDAQ:ZFGN) PT Means Stock Is Worth Almost $6 - Review Fortune (NASDAQ:ZFGN)
reviewfortune.com - July 25 at 8:38 PM
tradecalls.org logoZafgen (ZFGN) Shares are Down -55.84% - Trade Calls (NASDAQ:ZFGN)
www.tradecalls.org - July 25 at 5:16 AM
streetupdates.com logoNoteworthy Analysts Suggestions: Zafgen, Inc. (NASDAQ:ZFGN) , St. Jude Medical, Inc. (NYSE:STJ) - Street Updates (NASDAQ:ZFGN)
www.streetupdates.com - July 25 at 5:16 AM
News IconShares Stumbling of Late: Zafgen, Inc. (NASDAQ:ZFGN) - TGP (NASDAQ:ZFGN)
telanaganapress.com - July 23 at 9:40 AM
news.cmlviz.com logoOption Market: Zafgen Inc (NASDAQ:ZFGN) Risk Hits An Extreme High - CML News (NASDAQ:ZFGN)
news.cmlviz.com - July 22 at 8:13 PM
fortune.com logoZafgen, Inc. (NASDAQ:ZFGN) Insiders Look Optimistic About Prospects - Review Fortune (NASDAQ:ZFGN)
reviewfortune.com - July 22 at 8:13 PM
equities.com logoZafgen Inc. (ZFGN) is Trading Lower on Unusual Volume for July 21 - Equities.com (NASDAQ:ZFGN)
www.equities.com - July 22 at 8:13 PM
News IconBiotech Stocks To Put On Your Watch List: Zafgen, Inc. (NASDAQ:ZFGN), Celgene Corporation (NASDAQ:CELG) - The Voice Registrar (NASDAQ:ZFGN)
voiceregistrar.com - July 22 at 11:22 AM
News IconWorthy Stock Update: Zafgen (ZFGN) - News Oracle (NASDAQ:ZFGN)
www.newsoracle.com - July 22 at 11:22 AM
streetupdates.com logoNoteworthy Analysts Suggestions: Zafgen, Inc. (NASDAQ:ZFGN) , Evoke Pharma, Inc. (NASDAQ:EVOK) - Street Updates (NASDAQ:ZFGN)
www.streetupdates.com - July 22 at 11:22 AM
equities.com logoZafgen Inc. (ZFGN) is Trading Lower on Unusual Volume for July 20 - Equities.com (NASDAQ:ZFGN)
www.equities.com - July 22 at 11:22 AM
smarteranalyst.com logoCanaccord Weighs in on Zafgen Inc (ZFGN) in Wake of Suspended Development for Weight Loss Drug Beloranib - Smarter Analyst (NASDAQ:ZFGN)
www.smarteranalyst.com - July 22 at 11:22 AM
rttnews.com logoZafgen Inc. (ZFGN) Sank To A New Low After Development Of Beloranib Suspended (NASDAQ:ZFGN)
www.rttnews.com - July 21 at 11:16 AM
finance.yahoo.com logoThe Zacks Analyst Blog Highlights: Zafgen, Celgene, Amgen, AbbVie and Biogen (NASDAQ:ZFGN)
finance.yahoo.com - July 21 at 9:30 AM
News IconStock Bending Down in Today's Session: Zafgen, Inc. (NASDAQ:ZFGN) - TGP (NASDAQ:ZFGN)
telanaganapress.com - July 20 at 9:34 PM
fidaily.com logoFBR Capital Cuts Rating On Zafgen, Inc. (ZFGN) - Finance Daily (NASDAQ:ZFGN)
www.fidaily.com - July 20 at 9:34 PM
fidaily.com logoZafgen, Inc. (ZFGN) Hits 52-Week Low - Finance Daily (NASDAQ:ZFGN)
www.fidaily.com - July 20 at 9:34 PM
News IconHome Biotech Stocks Zafgen, Inc. | $ZFGN Stock | Shares Crash Down On Announcement Of... - TickerTV News (press release) (NASDAQ:ZFGN)
ticker.tv - July 20 at 9:34 PM
nasdaq.com logoZafgen Suspends Development Of Beloranib; Shares Plunge More Than 40% (NASDAQ:ZFGN)
www.nasdaq.com - July 20 at 11:19 AM
rttnews.com logoZafgen Inc. (ZFGN) Is Falling After Development Of Beloranib Suspended (NASDAQ:ZFGN)
www.rttnews.com - July 20 at 11:19 AM
streetinsider.com logoZafgen (ZFGN) to Suspend Beloranib Development; Will Refocus on MetAP2 Inhibitor ZGN-1061 (NASDAQ:ZFGN)
www.streetinsider.com - July 20 at 11:19 AM
fidaily.com logoFBR Capital Cuts Rating On Zafgen, Inc. (ZFGN) (NASDAQ:ZFGN)
www.fidaily.com - July 20 at 11:19 AM
investing.com logoZafgen Shares Crash Down On Announcement Of Cutting Workforce (NASDAQ:ZFGN)
www.investing.com - July 20 at 11:19 AM

Social

Zafgen (NASDAQ:ZFGN) Chart for Tuesday, September, 27, 2016


Last Updated on 9/27/2016 by MarketBeat.com Staff